|
|
||||||||
Animal: DNA Viruses |
ová1
árka N
me
ková1
ek2
Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20 Praha 2, Czech Republic1
Institute of Criminalistics, Strojírenská 27, Praha 7, Czech Republic2
Author for correspondence: Luda Kutinová.Fax +420 2 21977392.
It has been shown recently that the residual virulence of vaccinia virus (VV) is an important factor that influences the outcome of immunization with VV recombinants. This study focused on the correlation of the residual virulence of several VV recombinants with antibody responses against the strongly immunogenic extrinsic glycoprotein E of varicella-zoster virus and the weakly immunogenic extrinsic protein preS2S of hepatitis B virus and against VV proteins, with mice used as a model organism. Furthermore, the effects of mixing different recombinants on the antibody response were studied. The results obtained indicated that: (i) the antibody response depended on the residual virulence of the recombinants, more so in the case of the weakly immunogenic protein; (ii) the residual virulence, the growth rate of the VV recombinants in extraneural tissues and the immunogenicity were associated features; (iii) immunization with mixtures of two differently virulent recombinants or with unequal amounts of two similarly virulent recombinants sometimes led to the suppression of antibody response. The appearance of this suppression was dependent on three factors: the residual virulence of the recombinants, the immunogenicity of the extrinsic proteins and the ratio of the recombinants in the mixtures. Thus, the data obtained demonstrate that there are various limitations to the use of replicating VV recombinants for immunization purposes.
This article has been cited by other articles:
![]() |
L. Maresova, T. J. Pasieka, and C. Grose Varicella-Zoster Virus gB and gE Coexpression, but Not gB or gE Alone, Leads to Abundant Fusion and Syncytium Formation Equivalent to Those from gH and gL Coexpression J. Virol., October 1, 2001; 75(19): 9483 - 9492. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Ramírez, M. M. Gherardi, D. Rodríguez, and M. Esteban Attenuated Modified Vaccinia Virus Ankara Can Be Used as an Immunizing Agent under Conditions of Preexisting Immunity to the Vector J. Virol., August 15, 2000; 74(16): 7651 - 7655. [Abstract] [Full Text] |
||||
![]() |
L. Maresová, L. Kutinová, V. Ludvíková, R. Zák, M. Mares, and S. Nemecková Characterization of interaction of gH and gL glycoproteins of varicella-zoster virus: their processing and trafficking J. Gen. Virol., June 1, 2000; 81(6): 1545 - 1552. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |